Top ETF Of December & Its Best Stocks
Image: Bigstock
ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report) topped the list of the best-performing ETFs of December with impressive returns of about 41%.
The rally came amid the pandemic, which has led to a surge in the acceptance of the next-generation of healthcare solutions known as genomics. As researchers are focusing on implementing preventive and precautionary measures through newer concepts, the use of genomics amid the COVID-19 pandemic has yielded a few successful measures. As such, genomics has garnered enough attraction from across the world.
Genomics is a concept that involves the human gene and sequencing for treatment and study of several diseases or potential diseases. The genomics market is expected to witness a CAGR of about 13% during the period 2020-2024 to $17.23 billion. Most of the growth will be driven by the need for creating/upgrading genome databases.
Additionally, rising government funding, increase in the number of genomics projects, falling sequencing costs, and the entry of new players and start-ups in the genomics field are driving the growth of the market. The market is being further helped by the wave of mergers & acquisitions, and progress in the development of coronavirus vaccine or treatment.
Let’s take a closer look at the fundamentals of ARKG.
ARKG in Focus
ARKG is an actively managed ETF that focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments along with improvements and advancements in genomics into their business. With AUM of $6.2 billion, the fund holds 51 stocks in its basket with none accounting for more than 7.4% of assets. It charges 75 bps in annual fees and trades in average daily volume of 1.8 million shares.
Although most of the stocks in the fund’s portfolio delivered strong returns, a few gained at least 80% last month. Below we have highlighted the five best-performing stocks in the ETF with their respective positions in the basket:
Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any ...
more